Welcome visitor Log In - or - Register
0 items /
View Cart
Check Out
four ways
Quick Search:
Skip Navigation LinksHome > Kinase Inhibitors > EGFR Mutants > CO-1686 (Rociletinib)
CO-1686 (Rociletinib)
CO-1686 is an orally bioavailable, irreversible EGFR inhibitor, selectively targeting EGFRL858R/T790M mutant with a Ki value of 21 nM over Wt EGFR (Ki = 303 nM), currently in clinical evaluation for NSCLC treatment.
Catalog NO: CT-CO1686
Synonym: Rociletinib, AVL-301
CAS NO: 1374640-70-6
Mol. Formula: C27H28F3N7O3
MW: 555.6
** 99.9%, in vivo Grade Material, recrystallized off-white powder (pic attached), coming with a spot-on high-precision Quantitative Microanalysis. Bulk stock! Same day shipping.